Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetics and Pharmacodynamics of Metformin

NCT03686722 is registered in ClinicalTrials.gov with Mohamed Raslan as lead sponsor.

NCT NCT03686722
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03686722 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Co-administration of Metformin and Daclatasvir on the Pharmacokinetics and Pharmacodynamics of Metformin
Lead sponsor
Mohamed Raslan
Phase
Phase 1
Overall status
Completed
Start date
September 9, 2017
Completion date
December 6, 2017
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, drug interactions, hepatitis c